5.625
Alpha Teknova Inc stock is traded at $5.625, with a volume of 445.70K.
It is down -1.23% in the last 24 hours and down -29.79% over the past month.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
See More
Previous Close:
$5.68
Open:
$5.54
24h Volume:
445.70K
Relative Volume:
1.38
Market Cap:
$303.52M
Revenue:
$36.68M
Net Income/Loss:
$-36.78M
P/E Ratio:
-4.8491
EPS:
-1.16
Net Cash Flow:
$-26.75M
1W Performance:
+7.88%
1M Performance:
-29.79%
6M Performance:
+10.00%
1Y Performance:
+97.54%
Alpha Teknova Inc Stock (TKNO) Company Profile
Name
Alpha Teknova Inc
Sector
Phone
(831) 637-1100
Address
2451 BERT DRIVE, HOLLISTER
Compare TKNO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TKNO
Alpha Teknova Inc
|
5.63 | 303.52M | 36.68M | -36.78M | -26.75M | -1.16 |
![]()
ZTS
Zoetis Inc
|
162.46 | 73.33B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.12 | 47.80B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.38 | 46.89B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.32 | 18.62B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
131.53 | 13.99B | 612.78M | -86.37M | -62.91M | -0.87 |
Alpha Teknova Inc Stock (TKNO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-10-25 | Initiated | Craig Hallum | Buy |
Mar-12-24 | Downgrade | BTIG Research | Buy → Neutral |
Alpha Teknova Inc Stock (TKNO) Latest News
Teknova And Pluristyx Launch PluriFreeze Cryopreservation System To Streamline Cell Therapy - Nasdaq
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies - The Manila Times
Revolutionary Cell Therapy Preservation: Teknova's New PluriFreeze System Transforms Development Process - StockTitan
How the (TKNO) price action is used to our Advantage - Stock Traders Daily
Alpha Teknova, Inc. (NASDAQ:TKNO) Sees Large Increase in Short Interest - Defense World
Sector Update: Health Care Stocks Decline Wednesday Afternoon - TradingView
Sector Update: Health Care -March 12, 2025 at 08:46 am EDT - Marketscreener.com
Alpha Teknova, Pluristyx Partner to Produce, Distribute PluriFreeze for Cell Therapies -March 12, 2025 at 04:23 am EDT - Marketscreener.com
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies - The Manila Times
Alpha Teknova and Pluristyx Announce Collaboration to Commercialize PluriFreeze Cryopreservation System for Cell Therapies - Nasdaq
Teknova, Pluristyx announce collaboration over next-generation cell therapies - TipRanks
Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.67 - Yahoo Finance
Alpha Teknova, Inc. SEC 10-K Report - TradingView
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported And Analysts Have Been Lifting Their Price Targets - Simply Wall St
Alpha Teknova’s Earnings Call: Growth Amid Challenges - TipRanks
Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2024 Earnings Call Transcript - MSN
Positive Outlook for Alpha Teknova: Strong Financial Performance and Growth Potential - TipRanks
Alpha Teknova stock holds as KeyBanc maintains rating By Investing.com - Investing.com South Africa
Alpha Teknova stock holds as KeyBanc maintains rating - Investing.com India
Alpha Teknova: Strong Revenue Growth and Strategic Positioning Justify Buy Rating - TipRanks
Alpha Teknova: Q4 Earnings Snapshot - Midland Daily News
Alpha Teknova Reports Steady Revenue Growth in 2024 - TipRanks
Earnings call transcript: Alpha Teknova Q4 2024 shows revenue growth, stock edges up - Investing.com India
Alpha Teknova: Q4 Earnings Snapshot -March 04, 2025 at 05:12 pm EST - Marketscreener.com
Alpha Teknova, Inc. Q4 Loss Narrows - Nasdaq
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Alpha Teknova, Inc. Reports 3% Revenue Growth for 2024 and Provides 2025 Guidance of $39-42 Million - Nasdaq
Can Teknova's 110% Clinical Solutions Growth Offset Continued Losses? - StockTitan
Stock Index Futures Mixed as Investors Weigh Trump Tariffs - TradingView
Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Up 54.3% in February - Defense World
Alpha Teknova, Inc. (NASDAQ:TKNO) Stocks Pounded By 31% But Not Lagging Industry On Growth Or Pricing - Simply Wall St
Calculating The Fair Value Of Alpha Teknova, Inc. (NASDAQ:TKNO) - Simply Wall St
When the Price of (TKNO) Talks, People Listen - Stock Traders Daily
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - The Manila Times
Alpha Teknova, Inc. Scheduled to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Nasdaq
Q4 Earnings: Can Teknova's Critical Reagents Business Show Growth Momentum? - StockTitan
Nkcfo LLC Makes New Investment in Alpha Teknova, Inc. (NASDAQ:TKNO) - MarketBeat
Leading Driver In The Ready-To-Use Luria-Bertani LB Liquid Medium Market 2025: Surge In R&D Activities Driving - EIN News
Oruka Therapeutics (NASDAQ:ORKA) & Alpha Teknova (NASDAQ:TKNO) Head-To-Head Contrast - Defense World
Alpha Teknova (NASDAQ:TKNO) Shares Gap UpTime to Buy? - MarketBeat
Alpha Teknova (NASDAQ:TKNO) Earns Buy Rating from Analysts at Craig Hallum - MarketBeat
(TKNO) Technical Data - Stock Traders Daily
Here’s What Boosted Alpha Teknova (TKNO) in Q4 - Yahoo Finance
Craig-Hallum initiates Alpha Teknova stock with buy rating - MSN
HC Wainwright maintains $18 target on Enanta shares, affirms Buy - MSN
Alpha Teknova Inc Stock (TKNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alpha Teknova Inc Stock (TKNO) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Lowell Matthew | Chief Financial Officer |
Jul 12 '24 |
Buy |
1.24 |
40,322 |
49,999 |
128,376 |
Gunstream Stephen | President and CEO |
Jul 12 '24 |
Buy |
1.24 |
80,645 |
100,000 |
243,497 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):